...
首页> 外文期刊>Pediatric Research >Calcium and Sodium Transport Processes in Patients with Cystic Fibrosis. I. A Specific Decrease in Mg2|[plus]|-Dependent, Ca2|[plus]|-Adenosine Triphosphatase Activity in Erythrocyte Membranes from Cystic Fibrosis Patients
【24h】

Calcium and Sodium Transport Processes in Patients with Cystic Fibrosis. I. A Specific Decrease in Mg2|[plus]|-Dependent, Ca2|[plus]|-Adenosine Triphosphatase Activity in Erythrocyte Membranes from Cystic Fibrosis Patients

机译:囊性纤维化患者的钙和钠转运过程。 I.囊性纤维化患者红细胞膜中Mg2 | [+] |依赖性的Ca2 | [plus] |-腺苷三磷酸酶活性的特定降低

获取原文

摘要

Summary: Calcium-ATPase activity (Mg2+-dependent Ca2+-ATPase, ATP phosphohydrolase, EC 3.6.1.3) in erythrocyte membrane preparations from cystic fibrosis (CF) patients was greatly reduced compared to erythrocyte membranes from control subjects. The Km for calcium was found to be similar in the two groups; however, the Vmax, the maximal rate of activation of the Ca2+-ATPase, is reduced by 50% in the erythrocyte membrane preparations of the CF patients (P 2+-ATPase activity of erythrocyte membranes from CF patients was unchanged compared to the control subjects. No difference in the Na+,K+-ATPase activity in erythrocyte membranes from CF patients compared to control patients could be observed. This indicates that the Ca2+-ATPase activity noted in CF erythrocytes is not part of a generalized membrane or membrane-bound enzyme alteration. It remains to be determined whether this alteration in Ca2+-ATPase activity is directly related to a defect in calcium transport in these cells and is a generalized phenomenon in CF present in cell types more directly involved in secretion.Speculation: If the alteration in Mg2+-dependent Ca2+-ATPase activity is found to be specifically related to calcium transport in erythrocytes and general to other cell types in patients with CF, then it might indicate a basic alteration in the ability of these cells to transport calcium and might be important in the overall manifestation of the disease.
机译:摘要:与对照组相比,囊性纤维化(CF)患者的红细胞膜制剂中的钙ATP酶活性(Mg2 +依赖性Ca2 + -ATP酶,ATP磷酸水解酶,EC 3.6.1.3)大大降低。发现两组的钙的Km相似。但是,CF患者的红细胞膜制剂中的Vmax(Ca2 + -ATPase的最大激活速率)降低了50%(CF患者的红细胞膜的P 2 + -ATPase活性与对照组相比没有变化)与对照组相比,CF患者的红细胞膜Na +,K + -ATPase活性无差异,这表明CF红细胞中的Ca2 + -ATPase活性不是广义膜或膜结合酶的一部分Ca2 + -ATPase活性的这种改变是否与这些细胞中钙转运的缺陷直接相关,并且是存在于更直接参与分泌的细胞类型中的CF中的普遍现象,尚待确定。发现Mg2 +依赖的Ca2 + -ATPase活性与CF细胞中的钙转运特别相关,并且与CF患者的其他细胞类型有关,这可能表明这些细胞转运钙的能力的基本改变,可能对疾病的整体表现很重要。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号